Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy.
Natalie M ReizineBryan PetersonStephanie MoyaYan WangYi-Hung Carol Y H TanOliver S EngMalcolm BilimoriaErnst LengyelKiran Kalyan TuragaDaniel V T CatenacciPublished in: JCO precision oncology (2020)